Güven puanı 8/100
Dr. Peter MacCallum
👤 11 yıllık deneyim
7,672+
Patients seen
11
Years in practice
2
Publications
1
Languages spoken
Hakkında
Dr. Peter MacCallum is a senior lecturer in haematology at Barts and The London School of Medicine and Dentistry, Queen Mary University of London, and an honorary consultant haematologist at Barts Health NHS Trust in London. He has served as Head of Clinical and Laboratory Haematology since 2004.
Dr. MacCallum qualified in medicine from the University of Sheffield and trained in haematology in Manchester and London. He was an MRC Clinical Fellow based at St Bartholomew’s School of Medicine before being appointed to his current role in 1995. Since 1996, he has also been the clinical lead for thrombosis and anticoagulant services.
Dr. MacCallum has been a Principal Investigator in several trials of new oral anticoagulants for stroke prevention in atrial fibrillation and in the management of venous thromboembolism. He is the Chief Investigator of the UK-wide ORANGE study, examining outcomes of major bleeding in anticoagulated patients, and serves as the UK Chief Investigator for the GARFIELD-VTE study, a global cohort study on long-term outcomes of patients with newly diagnosed venous thromboembolism.
He has been involved in the development of national guidelines for the Royal College of Obstetricians and Gynaecologists on the prevention of venous thromboembolism during pregnancy and the puerperium, and has co-authored numerous papers and research in the field of thrombosis. His work includes studies on travel-related thrombosis, thrombotic markers in pregnancy-related issues, and fibrinolytic activation in trauma patients. Additionally, Dr. MacCallum has contributed as a reviewer for NICE clinical guidelines and has served as a specialist member of both the NICE Diagnostic Advisory Committee and the NICE Technology Appraisal Committee.
Dr. MacCallum qualified in medicine from the University of Sheffield and trained in haematology in Manchester and London. He was an MRC Clinical Fellow based at St Bartholomew’s School of Medicine before being appointed to his current role in 1995. Since 1996, he has also been the clinical lead for thrombosis and anticoagulant services.
Dr. MacCallum has been a Principal Investigator in several trials of new oral anticoagulants for stroke prevention in atrial fibrillation and in the management of venous thromboembolism. He is the Chief Investigator of the UK-wide ORANGE study, examining outcomes of major bleeding in anticoagulated patients, and serves as the UK Chief Investigator for the GARFIELD-VTE study, a global cohort study on long-term outcomes of patients with newly diagnosed venous thromboembolism.
He has been involved in the development of national guidelines for the Royal College of Obstetricians and Gynaecologists on the prevention of venous thromboembolism during pregnancy and the puerperium, and has co-authored numerous papers and research in the field of thrombosis. His work includes studies on travel-related thrombosis, thrombotic markers in pregnancy-related issues, and fibrinolytic activation in trauma patients. Additionally, Dr. MacCallum has contributed as a reviewer for NICE clinical guidelines and has served as a specialist member of both the NICE Diagnostic Advisory Committee and the NICE Technology Appraisal Committee.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr. Peter MacCallum
Eğitim ve öğretim
-
2005–2011 MD · Medicine and Surgery
-
2011–2015 Residency · Hematoloji
Kariyer ve atamalar
-
2015-09–2016-08 Junior consultant
Lisanslar ve sigorta
Tıbbi lisanslar
GB — Organización Médica Colegial de España (OMC)
Kurul sertifikaları
European Board of Hematoloji
Mesleki sorumluluk sigortası:
AmTrust Europe · 5,000,000 EUR kapsam · No claims on file
Gerçekleştirilen prosedürler
| Prosedür | Kod | Toplam sayı |
|---|---|---|
| GP consultation | 99213 | 2,615 |
| Annual physical exam | 99395 | 2,473 |
| Vaccination administration | 90471 | 2,921 |
| Minor procedure (skin) | 17110 | 1,494 |
Hizmetler ve fiyatlandırma
| Hizmet | Süre | Yöntem | Fiyat |
|---|---|---|---|
| New patient consultation (60m) | 60 dk | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 dk | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 dk | in_clinic | 810.00 EUR |
| Minor procedure (skin) | 30 dk | in_clinic | 540.00 EUR |
Ofis, ekip ve uygulamada
Videolar
Araştırma ve yayınlar
h-endeksi: 11 · i10: 6
-
Validation of clinical scoring in Hematoloji
DOI: 10.1656/euroclin.2026.0 · PMID: 31798921 · alıntılayan 119
-
Long-term follow-up of Hematoloji across GB
DOI: 10.2978/euroclin.2025.1 · PMID: 34680255 · alıntılayan 29
Davetli konuşmalar
- Practical updates in Hematoloji European Annual Congress (Hematoloji) · Vienna · 2024 · invited
- Single-centre experience in Hematoloji National Society Meeting · London · 2023 · oral abstract
Ödüller ve üyelikler
Ödüller
- 🏆 Top-rated Hematoloji — London · EuroClinics Patient Choice · 2025 · regional
Topluluk üyelikleri
- WONCA Europe — Family Doctors — Member · 2016 yılından beri
- national college of family doctors — Member · 2016 yılından beri
- European Union of Medical Specialists (UEMS) — Member · 2016 yılından beri
Bu doktorun makaleleri
- Patient education Patient guide to Hematoloji
- Awareness When should you see a hematoloji?
Uluslararası hastalar için
- Koordinatör
- Patient liaison · peter.maccallum@euroclinics.example
Konum
1 etiketHasta yorumları
Deneyiminizi paylaşın — diğer hastaların doğru doktoru bulmasına yardımcı olun. Yorum yaz →
Son yorumlar
-
★★★★★ ✓ Doğrulanmış Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Doğrulanmış Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Doğrulanmış Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.